Literature DB >> 7744838

Structure-function analysis of human glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a.

K J Lei1, C J Pan, J L Liu, L L Shelly, J Y Chou.   

Abstract

Glucose-6-phosphatase (G6Pase) is the enzyme deficient in glycogen storage disease type 1a, an autosomal recessive disorder. We have previously identified six mutations in the G6Pase gene of glycogen storage disease type 1a patients and demonstrated that these mutations abolished or greatly reduced enzymatic activity of G6Pase, a hydrophobic protein of 357 amino acids. Of these, four mutations (R83C, R295C, G222R, and Q347X) are missense and one (Q347X) generates a truncated G6Pase of 346 residues. To further understand the roles and structural requirements of amino acids 83, 222, 295, and those at the carboxyl terminus in G6Pase catalysis, we characterized mutant G6Pases generated by near-saturation mutagenesis of the aforementioned amino acids. Substitution of Arg-83 with amino acids of diverse structures including Lys, a conservative change, yielded mutant G6Pase with no enzymatic activity. On the other hand, substitution of Arg-295 with Lys (R295K) retained high activity, and R295N, R295S, and R295Q exhibited moderate activity. All other substitutions of Arg-295 had no G6Pase activity, suggesting that the role of Arg-295 is to stabilize the protein either by salt bridge or hydrogen-bond formation. Substitution of Gly-222, however, remained functional unless a basic (Arg or Lys), acidic (Asp), or large polar (Gln) residue was introduced, consistent with the hydrophobic requirement of codon 222, which is predicted to be in the fourth membrane-spanning domain. It is possible that Arg-83 is involved in stabilizing the enzyme (His)-phosphate intermediate formed during G6Pase catalysis. There exist 9 conserved His residues in human G6Pase. His-9, His-119, His-252, and His-353 reside on the same side of the endoplasmic reticulum membrane as Arg-83. Whereas H119A mutant G6Pase had no enzymatic activity, H9A, H252A, and H353A mutant G6Pases retained significant activity. Substitution of His-119 with amino acids of diverse structures also yielded mutant G6Pase with no activity, suggesting that His-119 is the phosphate acceptor in G6Pase catalysis. We also present data demonstrating that the carboxyl-terminal 8 residues in human G6Pase are not essential for G6Pase catalysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744838     DOI: 10.1074/jbc.270.20.11882

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  X-ray structures of a novel acid phosphatase from Escherichia blattae and its complex with the transition-state analog molybdate.

Authors:  K Ishikawa; Y Mihara; K Gondoh; E Suzuki; Y Asano
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Isolation, cloning, and expression of an acid phosphatase containing phosphotyrosyl phosphatase activity from Prevotella intermedia.

Authors:  X Chen; T Ansai; S Awano; T Iida; S Barik; T Takehara
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

3.  Liver glucose-6-phosphatase proteins in suckling and weaned grey seal pups: structural similarities to other mammals and relationship to nutrition, insulin signalling and metabolite levels.

Authors:  K A Bennett; M Hammill; S Currie
Journal:  J Comp Physiol B       Date:  2013-06-07       Impact factor: 2.200

Review 4.  Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Hum Mutat       Date:  2008-07       Impact factor: 4.878

5.  Mutation analysis in 24 French patients with glycogen storage disease type 1a.

Authors:  F Chevalier-Porst; D Bozon; A M Bonardot; N Bruni; G Mithieux; M Mathieu; I Maire
Journal:  J Med Genet       Date:  1996-05       Impact factor: 6.318

6.  From phosphatases to vanadium peroxidases: a similar architecture of the active site.

Authors:  W Hemrika; R Renirie; H L Dekker; P Barnett; R Wever
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

7.  Identification of structurally important domains of lipid phosphate phosphatase-1: implications for its sites of action.

Authors:  Q X Zhang; C S Pilquil; J Dewald; L G Berthiaume; D N Brindley
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

8.  Crystal structure of lipid phosphatase Escherichia coli phosphatidylglycerophosphate phosphatase B.

Authors:  Junping Fan; Daohua Jiang; Yan Zhao; Jianfeng Liu; Xuejun Cai Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

9.  Recent development and gene therapy for glycogen storage disease type Ia.

Authors:  Janice Y Chou; Goo-Young Kim; Jun-Ho Cho
Journal:  Liver Res       Date:  2017-09

10.  Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism.

Authors:  Sakine Sever; David A Weinstein; Joseph I Wolfsdorf; Reyhan Gedik; Ernst J Schaefer
Journal:  J Clin Lipidol       Date:  2012-08-30       Impact factor: 4.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.